1Park CH, Kim KB, Han J, et al. Cardiac damage biomarkers following a triathlon in elite and non-elite triathletes [ J]. Korean J Physiol Pharmacol, 2014, 18(5) : 419-423.
2Kim JH, Chung HS, Antonisamy P, et al. Cardioprotective effect of rhizomes of Acorus gramineus against isoproterenol-induced cardiac damage in pigs [J]. Cardiovasc Toxicol, 2014, 14(2) : 183-192.
3Starnberg K, Jeppsson A, Lindahl B, et al. Revision of the troponin T release mechanism from damaged human myocardium [J]. Clin Chem, 2014, 60(8) : 1098-1104.
4Lotrionte M, Palazzoni G, Natali R, et al. Appraising eardiotoxi- city associated with liposomal doxorubicin by means of tissue Doppler echocardiography end-points: rationale and design of the LITE ( Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study [ J ]. Int J Cardiol, 2009, 135(1): 72-77.
6Mari Kannan M, Darlin Quine S. Pharmacodynamics of ellagic acid on cardiac troponin-T, lyosomal enzymes and membrane bound ATPases: mechanistic clues from biochemical, eytokine and in vitro studies [J]. Chem Biol Interact, 2011, 193(2): 154-161.
7Lipshultz SE, Scully RE, Lipsitz SR, et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow- up of a prospective, randomised, multicentre trial [ J ]. Lancet Oncol, 2010, 11(10) : 950-961.
8Karadeniz L, Coban A, Ince Z, et al. Cord blood cardiac troponin T and nonprotein-bound iron levels in newborns of mild pre-eclamptic mothers [ J ]. Neonatology, 2010, 97 (4) : 305- 310.
9Ozdemir O, Oguz D, Atmaca E, et al. Cardiac troponin T in children with acute rheumatic carditis [ J ]. Pediatr Cardiol, 2011, 32(1): 55-58.
10Palladini G, Barassi A, Klersy C, et al. The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT- proBNP) after chemotherapy best predicts survival in AL amvloidosis [ J ]. Blood. 2010. 116 ( 18 ) : 3426-3430.
